424 studies found for:    Wilson Disease
Show Display Options
Rank Status Study
1 Completed
Has Results
Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
Condition: Wilson Disease
Intervention: Drug: Once a day Trientine
2 Completed Study of Zinc for Wilson Disease
Condition: Wilson Disease
Intervention: Drug: zinc acetate
3 Completed
Has Results
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Condition: Wilson's Disease
Intervention: Drug: NPC-02
4 Completed A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients
Condition: Wilson's Disease
Intervention: Drug: trientine dihydrochloride
5 Completed Study of Tetrathiomolybdate in Patients With Wilson Disease
Condition: Wilson Disease
Interventions: Drug: tetrathiomolybdate;   Drug: trientine
6 Recruiting Inhibitory rTMS in Dystonic Wilson Patients
Conditions: Wilson Disease;   Movement Disorders;   Repetitive Transcranial Magnetic Stimulation
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS);   Other: pre and post-rTMS electroencephalogram;   Other: WCRS;   Other: handwriting scale DPRE;   Other: visual analog scale of discomfort writing and parameters collected on touchpad
7 Completed Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Condition: Wison's Disease
Intervention: Drug: Zinc acetate
8 Unknown  Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis
Condition: Wilson's Disease
Intervention: Genetic: allogeneic mesenchymal stem cell transplantation
9 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
10 Not yet recruiting ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
Conditions: Movement Disorders;   Essential Tremor;   Holmes Tremor;   Parkinson's Disease;   Wilson's Disease;   Huntington's Disease;   Dystonia;   Tardive Dyskinesia;   Orofacial Dyskinesias
Intervention: Device: Transcranial ExAblate System
11 Unknown  Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)
Conditions: SIRS;   Sepsis;   Liver Disease
Intervention:
12 Completed A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris
Condition: Psoriasis
Intervention: Drug: Tetrathiomolybdate (TM)
13 Recruiting A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: Vemurafenib and Trientine
14 Completed Phase I Study of Disulfiram and Copper Gluconate for the Treatment of Refractory Solid Tumors Involving the Liver
Condition: Cancer
Interventions: Drug: Disulfiram;   Drug: Copper Gluconate
15 Completed Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
Conditions: Fatty Liver Disease.;   Endoscopic Ultrasound Tru-Cut Biopsy.
Intervention: Device: EUS Tru-cut biopsy
16 Not yet recruiting Interstitial Lung Disease Questionnaire
Condition: Interstitial Lung Disease
Intervention:
17 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
Intervention:
18 Not yet recruiting Platelet-Rich Plasma Versus Corticosteroid Injection as Treatment for Degenerative Pathology of the Temporomandibular Joint
Condition: Degenerative Joint Disease
Interventions: Drug: Group A (corticosteroid injection group);   Biological: Group B (platelet rich plasma injection group)
19 Active, not recruiting Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Condition: Hyperphosphatemia
Intervention:
20 Terminated
Has Results
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: thalidomide;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years